The Infectious Diseases Society of America and the American Society for Microbiology have published a guide to help physicians determine which tests are most useful in diagnosing infectious diseases. ... The guide was published in the Aug. 15 Clinical
Results were published by Clinical Infectious Diseases on July 23. The overall rate of DTR in gram-negative bloodstream infections was 1%, with rates ranging from 0.04% for Escherichia coli
Antibiotics are one source of disagreement and a reason that the Infectious Diseases Society of America (IDSA) declined to endorse the most recent Surviving Sepsis Campaign (SSC) guidelines, which were published ... However, the IDSA's response paper
The guidance was endorsed by the Society of Hospital Medicine, the Association for Professionals in Infection Control and Epidemiology, and the Association of Medical Microbiology and Infectious Disease Canada.
Vazquez, MD, FACP, a professor of medicine and chief of the division of infectious diseases at the Medical College of Georgia at Augusta University. ... auris frequently masquerades as other Candida species, said Dr. Clancy, who is also chief of the
Results were published online on Sept. 11 by Clinical Infectious Diseases.
The full recommendations were published by Stroke on May 28. The Infectious Diseases Society of America has issued updated guidelines for the diagnosis and management of intravascular catheter-related infections. ... The guidelines appeared in the July 1
Empirical therapy covering methicillin-resistant Staphylococcus aureus (MRSA) was associated with an increased risk of 30-day mortality compared to standard antibiotics in veterans hospitalized with pneumonia, including those with clinical risk
Only 21.7% of the patients who received OPAT met the Infectious Diseases Society of America's (IDSA) 2001 criteria to be treated as an outpatient. ... Results were published by Clinical Infectious Diseases on Jan. 14. Of the patients who received OPAT, 57
Results were published by Clinical Infectious Diseases on April 27. Slightly more than half of the patients (51.5%) received empirical covering antibiotics, with colistin being the in vitro covering antibiotic